Wymeswold, United Kingdom

David E Hall

This inventor holds 5 USPTO granted patents. Top assignee: Fisons Ltd.. Active years: 1978-1990.


% Patents Active = 100.0

Average Co-Inventor Count = 3.4

ph-index = 3

Forward Citations = 81(Granted Patents)


Location History:

  • Burton-on-the-Wolds, EN (1978)
  • Burton-on-the-Wolds, GB (1979 - 1980)
  • Loughborough, GB (1989)
  • Wymeswold, GB (1990)

Company Filing History:


Years Active: 1978-1990

Loading Chart...
5 patents (USPTO):Explore Patents

Title: The Innovative Contributions of David E Hall

Introduction

David E Hall is a notable inventor based in Wymeswold, Great Britain. He has made significant contributions to the field of chemistry, particularly in the development of various compounds. With a total of 5 patents to his name, Hall's work has had a considerable impact on his industry.

Latest Patents

Among his latest patents are innovative compounds such as 2-Pyridinyl-phenyl-sulphinyl-and-phenyl-thio-benzimidazoles. These compounds are characterized by a specific formula where A is a 5 or 6 membered, fully unsaturated, carbocyclic or heterocyclic ring. Additionally, he has developed certain 2-pyridinyl-phenylsulfinyl-benzoxazoles, which also follow a defined formula where A is a benzene or heterocyclic ring, and y can be 0 or 1.

Career Highlights

David E Hall has had a successful career, working with Fisons Ltd., a company known for its advancements in pharmaceuticals and chemicals. His innovative work has contributed to the company's reputation in the industry.

Collaborations

Throughout his career, Hall has collaborated with notable colleagues, including Thomas S Orr and John Mann. These partnerships have fostered a creative environment that has led to the development of groundbreaking inventions.

Conclusion

David E Hall's contributions to the field of chemistry through his patents and collaborations highlight his role as an influential inventor. His work continues to inspire innovation in the industry.

Profile summary based on public USPTO records.
Please report any incorrect information to [email protected]
Loading…